View as an RSS Feed
View Mark S. Anderson's Articles BY TICKER:
Why They Have It Wrong About Zogenix And You Would Be Right To Buy
- Zohydro is the least potent of the extended-release painkillers.
- ZGNX's 52-week high is $5.19, currently more than a 40% drop to $3.04 on misinformation being released.
- One of the only two extended-release painkillers that achieved less than 2% adverse effects.